Duloxetine for Treatment of Painful Temporomandibular Joint Disorder
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Temporomandibular joint disorders (TMJD) are a family of musculoskeletal disorders that
represent the most common chronic orofacial pain condition. TMJD is associated with
persistent pain in the region of the temporomandibular joint and muscles of the head and
neck. The purpose of this study is to test duloxetine (Cymbalta) as a potential treatment for
chronic facial pain. Duloxetine is FDA approved as an antidepressant and for the chronic pain
conditions of fibromyalgia and diabetic neuropathy. Chronic facial pain may be linked to
Temporomandibular Joint Disorder (TMJD) which currently has no standard treatment.
Phase:
N/A
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore